154 related articles for article (PubMed ID: 16600935)
1. Greater whole-body myofibrillar protein breakdown in cachectic patients with chronic obstructive pulmonary disease.
Rutten EP; Franssen FM; Engelen MP; Wouters EF; Deutz NE; Schols AM
Am J Clin Nutr; 2006 Apr; 83(4):829-34. PubMed ID: 16600935
[TBL] [Abstract][Full Text] [Related]
2. Hydrolyzed casein and whey protein meals comparably stimulate net whole-body protein synthesis in COPD patients with nutritional depletion without an additional effect of leucine co-ingestion.
Jonker R; Deutz NE; Erbland ML; Anderson PJ; Engelen MP
Clin Nutr; 2014 Apr; 33(2):211-20. PubMed ID: 23886411
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary cachexia, systemic inflammatory profile, and the interleukin 1beta -511 single nucleotide polymorphism.
Broekhuizen R; Grimble RF; Howell WM; Shale DJ; Creutzberg EC; Wouters EF; Schols AM
Am J Clin Nutr; 2005 Nov; 82(5):1059-64. PubMed ID: 16280439
[TBL] [Abstract][Full Text] [Related]
4. Metabolic effects of glutamine and glutamate ingestion in healthy subjects and in persons with chronic obstructive pulmonary disease.
Rutten EP; Engelen MP; Wouters EF; Schols AM; Deutz NE
Am J Clin Nutr; 2006 Jan; 83(1):115-23. PubMed ID: 16400059
[TBL] [Abstract][Full Text] [Related]
5. The effects of cachexia and related components on pulmonary functions in patients with COPD.
Görek Dilektaşli A; Ulubay G; Bayraktar N; Eminsoy I; Oner Eyüboğlu F
Tuberk Toraks; 2009; 57(3):298-305. PubMed ID: 19787469
[TBL] [Abstract][Full Text] [Related]
6. Decreased whole-body and splanchnic glutamate metabolism in healthy elderly men and patients with chronic obstructive pulmonary disease in the postabsorptive state and in response to feeding.
Rutten EP; Engelen MP; Castro CL; Wouters EF; Schols AM; Deutz NE
J Nutr; 2005 Sep; 135(9):2166-70. PubMed ID: 16140893
[TBL] [Abstract][Full Text] [Related]
7. Effects of cachexia due to cancer on whole body and skeletal muscle protein turnover.
Dworzak F; Ferrari P; Gavazzi C; Maiorana C; Bozzetti F
Cancer; 1998 Jan; 82(1):42-8. PubMed ID: 9428478
[TBL] [Abstract][Full Text] [Related]
8. Enhanced levels of whole-body protein turnover in patients with chronic obstructive pulmonary disease.
Engelen MP; Deutz NE; Wouters EF; Schols AM
Am J Respir Crit Care Med; 2000 Oct; 162(4 Pt 1):1488-92. PubMed ID: 11029366
[TBL] [Abstract][Full Text] [Related]
9. Sex related differences in muscle health and metabolism in chronic obstructive pulmonary disease.
Engelen MPKJ; Kirschner SK; Coyle KS; Argyelan D; Neal G; Dasarathy S; Deutz NEP
Clin Nutr; 2023 Sep; 42(9):1737-1746. PubMed ID: 37542951
[TBL] [Abstract][Full Text] [Related]
10. Preserved anabolic threshold and capacity as estimated by a novel stable tracer approach suggests no anabolic resistance or increased requirements in weight stable COPD patients.
Jonker R; Deutz NEP; Ligthart-Melis GC; Zachria AJ; Veley EA; Harrykissoon R; Engelen MPKJ
Clin Nutr; 2019 Aug; 38(4):1833-1843. PubMed ID: 30100106
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of essential amino acid supplementation in stimulating whole body net protein anabolism is comparable between COPD patients and healthy older adults.
Jonker R; Deutz NE; Erbland ML; Anderson PJ; Engelen MP
Metabolism; 2017 Apr; 69():120-129. PubMed ID: 28285641
[TBL] [Abstract][Full Text] [Related]
12. Whole-body resting and exercise-induced lipolysis in sarcopenic [corrected] patients with COPD.
Franssen FM; Sauerwein HP; Rutten EP; Wouters EF; Schols AM
Eur Respir J; 2008 Dec; 32(6):1466-71. PubMed ID: 18579550
[TBL] [Abstract][Full Text] [Related]
13. Oxidative stress, redox signaling pathways, and autophagy in cachectic muscles of male patients with advanced COPD and lung cancer.
Puig-Vilanova E; Rodriguez DA; Lloreta J; Ausin P; Pascual-Guardia S; Broquetas J; Roca J; Gea J; Barreiro E
Free Radic Biol Med; 2015 Feb; 79():91-108. PubMed ID: 25464271
[TBL] [Abstract][Full Text] [Related]
14. Skeletal muscle and whole body protein turnover in cardiac cachexia: influence of branched-chain amino acid administration.
Morrison WL; Gibson JN; Rennie MJ
Eur J Clin Invest; 1988 Dec; 18(6):648-54. PubMed ID: 3147192
[TBL] [Abstract][Full Text] [Related]
15. The mechanisms of cachexia underlying muscle dysfunction in COPD.
Remels AH; Gosker HR; Langen RC; Schols AM
J Appl Physiol (1985); 2013 May; 114(9):1253-62. PubMed ID: 23019314
[TBL] [Abstract][Full Text] [Related]
16. The phosphodiesterase-4 inhibitor roflumilast reverts proteolysis in skeletal muscle cells of patients with COPD cachexia.
Barreiro E; Puig-Vilanova E; Salazar-Degracia A; Pascual-Guardia S; Casadevall C; Gea J
J Appl Physiol (1985); 2018 Aug; 125(2):287-303. PubMed ID: 29648516
[TBL] [Abstract][Full Text] [Related]
17. Anorexia in chronic obstructive pulmonary disease--association to cachexia and hormonal derangement.
Koehler F; Doehner W; Hoernig S; Witt C; Anker SD; John M
Int J Cardiol; 2007 Jun; 119(1):83-9. PubMed ID: 17064790
[TBL] [Abstract][Full Text] [Related]
18. Protein breakdown on whole-body and organ level in non-cachectic tumour-bearing mice undergoing surgery.
Vissers YL; von Meyenfeldt MF; Argilés JM; Luiking YC; Dejong CH; Deutz NE
Clin Nutr; 2007 Aug; 26(4):483-90. PubMed ID: 17513024
[TBL] [Abstract][Full Text] [Related]
19. Increased contribution by myofibrillar protein to whole-body protein breakdown according to severity of surgical stress.
Tashiro T; Yamamori H; Takagi K; Morishima Y; Nakajima N
Nutrition; 1996 Oct; 12(10):685-9. PubMed ID: 8936491
[TBL] [Abstract][Full Text] [Related]
20. Increased serum levels of S100A1, ZAG, and adiponectin in cachectic patients with COPD.
Mokari-Yamchi A; Sharifi A; Kheirouri S
Int J Chron Obstruct Pulmon Dis; 2018; 13():3157-3163. PubMed ID: 30349224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
